Legal Feasibility of AI Implementation in Indonesian Pharmaceutical Services

  • Sabda Wahab Universitas Kader Bangsa
  • Hilda Muliana Universitas Batam
  • Ronny Sutanto Universitas Muhammadiyah Sidoarjo
  • Nia Azzahra Universitas Kader Bangsa
Keywords: Artificial Intelligence, Pharmaceutical Services, Health Law, Consumer Protection, Legal Liability

Abstract

The development of Artificial Intelligence (AI) offers significant potential to improve efficiency, accuracy, and personalization in pharmaceutical services. However, Indonesia lacks a specific legal framework to regulate its application, especially regarding patient protection and professional accountability. This study aims to analyze the compatibility of AI use in pharmaceutical services with principles of health law and consumer protection, and to identify legal gaps concerning liability for AI-induced harm. Using a normative juridical method, the study examines relevant laws and legal literature. The findings show that Indonesia’s positive law does not yet regulate informed consent, algorithm validation, or legal responsibility in AI-based pharmaceutical services. This legal vacuum risks undermining patient rights. The study recommends sectoral regulations that address AI validation, independent audits, data protection, and liability frameworks tailored to AI characteristics, ensuring ethical and legally accountable implementation.

Downloads

Download data is not yet available.

References

Anastasya, Gracia, and Miski A. Khairinisa. “The Rise of Artificial Intelligence in Pharmacy: Transforming Medication Management and Patient Care.” Pharmacology and Clinical Pharmacy Research 9, no. 2 (2024): 142–155.

Aulia Anugrah Intani, and Fauza Annisa. “Legal Analysis of Artificial Intelligence Technology Development in Healthcare Industry in Indonesia.” South-East Asian Journal of Advanced Law and Governance (SEAJ ALGOV) 1, no. 1 (2024): 1–19.

Bidara, Farah, and Nadya Putri Auliya Serawaidi. “Literature Review: Peluang Dan Tantangan Penggunaan Keceerdasan Buatan Dalam Meningkatkan Pelayanan Farmasi Klinis.” Jurnal Kesehatan Mahardika 12, no. 1 (2025): 158–171.

Biplawfirm.id. “Artificial Intelligence Dalam Perspektif Hukum: Perkembangan, Regulasi, Dan Aspek Kesehatandi Indonesia.” https://biplawfirm.id/artificial-intelligence-dalam-perspektif-hukum-perkembangan-regulasi-dan-aspek-kesehatandi-indonesia/?utm_source=chatgpt.com.

Del Río, Ana Fernández, Michael Brennan Leong, Paulo Saraiva, Ivan Nazarov, Aditya Rastogi, Moiz Hassan, Dexian Tang, and África Periáñez. “Adaptive Behavioral AI: Reinforcement Learning to Enhance Pharmacy Services” (2024).

Dwi, Ardian, Cahya Firza, Kevin Samudera, and Aurellia Saphira. “Legal Arrangement of Artificial Intelligence in Indonesia : Challenges and Opportunities.” Jurnal Peradaban Hukum 1, no. 2 (2023): 14–29.

Dwi Kurniawan, Kukuh, and Dwi Ratna Indri Hapsari. “Pertanggungjawaban Pidana Korporasi Menurut Vicarious Liability Theory.” Jurnal Hukum Ius Quia Iustum 29, no. 2 (2022): 324–346.

Ikhsan, Muhammad, and Sabda Wahab. “Kepastian Hukum Tenaga Kefarmasian Dalam Menyelenggarakan Pelayanan Kefarmasian.” Jurnal Hukum Kesehatan Indonesia 01, no. 02 (2021): 106–120.

Irene, Liana Salwa, Christian Andersen, and Universitas Kristen Maranatha. “The Implementation of the Strict Liability Principle in Legal Liability of Artificial Intelligence in Indonesia ’ s Healthcare Sector” 5, no. 6 (2025): 5171–5180.

Masinton Pasaribu. “Penerapan Kecerdasan Buatan (Artificial Intelligence) Dalam Proses Legislasi Dan Sistem Peradilan Di Indonesia.” Jurnal Hukum dan Bisnis (Selisik) 10, no. 2 (2024): 163–181.

Mita, Ermita Ekalia, Ariawan Gunadi, and Muhammad Abdurrohim. “Pengembangan Regulasi Penggunaan Artificial Intelligence Pada Bidang Kesehatan Di Indonesia Pada Aspek Hukum Dan Etika.” Jurnal Ilmu Hukum, Humaniora dan Politik 5, no. 2 (2024): 1518–1533.

Pagallo, U. “The Legal Challenges of Big Data: Putting Secondary Rules First in the Field of EU Data Protection.” European Data Protection Law Review 3, no. 1 (2017): 1–11.

Ramli M. Ahmad. “Regulasi Penggunaan AI Dalam Layanan Kesehatan Dan Industri Vaksin.” Kompas. Last modified September 16, 2024. Accessed July 25, 2025. https://health.kompas.com/read/24I16095325468/regulasi-penggunaan-ai-dalam-layanan-kesehatan-dan-industri-vaksin?utm_source.

Rasyidah, Nur Aliya, Muhammad Aksay, and Muhammad Firdaus Akmal. “Urgensi Pembuatan Regulasi Penggunaan AI (Artificial Intelligence) Di Indonesia.” Jurnal Penegakan Hukum Indonesia 5, no. 1 (2024): 42–51.

Rayyan, Rayga, Marice Simarmata, Fakultas Pascasarjana, Program Studi, Magister Hukum, and Pembangunan Panca Budi. “Kepastian Hukum Penggunaan Artificial Intelligence ( AI ) Dalam Pelayanan Kesehatan Dan Diagnosa Medis Di Indonesia” 2 (2025).

SSEK Law Firm. “Regulation of Artificial Intelligence in Indonesia.” SSEK Law Firm. Last modified February 29, 2024. Accessed July 24, 2025. https://ssek.com/blog/indonesia-law-update-regulation-of-artificial-intelligence/?utm_source.

Wahyuni, Willa. “AI Di Bidang Kesehatan Mulai Diterapkan, Ini Yang Perlu Diketahui.” Hukum Online. Last modified February 21, 2025. Accessed July 25, 2025. https://www.hukumonline.com/berita/a/ai-di-bidang-kesehatan-mulai-diterapkan--ini-yang-perlu-diketahui-lt67b8769b47f28/?utm_source.

WHO. Ethics And Governance Of Artificial Intelligence For Health. WHO, 2021.

Published
2025-07-29
How to Cite
Wahab, S., Muliana, H., Sutanto, R., & Azzahra, N. (2025). Legal Feasibility of AI Implementation in Indonesian Pharmaceutical Services. SOL JUSTICIA, 8(1), 48-58. https://doi.org/10.54816/sj.v8i1.1051
Section
Articles